Both in Biotechnology
Exelixis vs Vaxcyte
Over the past year EXEL returned +90.0% and PCVX returned +42.0%; their daily moves had a correlation of 0.30.
EXEL +90.0% PCVX +42.0%Growth of $1, one year, split-adjusted
| Metric | EXEL | PCVX |
|---|---|---|
| Price | $72.31 | $60.81 |
| Market cap | $17.64B | $9.57B |
| Today | +3.11% | +0.31% |
| 1 month | +22.9% | −17.6% |
| 6 months | +62.8% | +9.3% |
| Year to date | +65.0% | +31.8% |
| 1 year | +87.0% | +34.3% |
| Revenue growth (YoY) | +10.2% | — |
| Gross margin | 96.0% | — |
| Net margin | 33.1% | — |
| P/E (TTM) | 19.9× | — |
| Price / sales | 7.1× | — |
| Net cash | $892.0M | $1.49B |
| Dividend yield | — | — |
| Volatility (60d) | 26.8% | 70.6% |
| Short % of float | 11.4% | 11.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).